Healthcare Industry News: bone graft
News Release - October 25, 2007
Medtronic Releases New Fixation System for the SpineNew System Gives Surgeons an Option When Treating Spinal Fractures and Tumors
MEMPHIS, Tenn.--(HSMN NewsFeed)--Medtronic, Inc. (NYSE:MDT ) announced today the availability of its CD Horizon® Legacy™ Anterior Spinal System in the United States. The CD Horizon Legacy Anterior Spinal System is a recent system that offers an anterior (frontal) fixation solution for complex spinal surgery. This fixation system is designed to assist with stability of the thoracic and lumbar spine when performing modern spinal fusion surgery. This new system may help patients suffering from degenerative disc disease, trauma, tumors, severe curvatures and other degenerative diseases of the spine.
The CD Horizon Legacy Anterior Spinal System consists of a series of vertebral body staples, rods, screws, Crosslink® Plates, and connecting components that allows for distraction to accommodate bone graft.
“The new CD Horizon Legacy Anterior Spinal System affords the surgeon a flexibility not previously available in other spinal systems for the treatment of tumor, trauma and deformity cases,” said David G. Schwartz, M.D., an orthopedic surgeon with Orthopaedics Indianapolis in Indiana.
The CD Horizon Legacy Anterior Spinal System also features:
- Titanium construction
- Low profile screw design
- Top-loading, top-tightening screws
- Color coding to assist with construct implantation
About the Spinal and Biologics Business at Medtronic
The Medtronic Spinal and Biologics business, based in Memphis, Tenn., is the global leader in today’s spine market and is committed to advancing the treatment of spinal conditions. The Spinal business collaborates with world-renowned surgeons, researchers and innovative partners to offer state-of-the-art therapies for spinal, neurological, orthopaedic and oral maxillofacial conditions. Medtronic is committed to developing affordable, minimally invasive procedures that provide lifestyle friendly surgical therapies. More information about the company and its spinal treatments can be found at www.medtronicspinal.com and its patient-education Web sites, www.back.com, www.iscoliosis.com, www.maturespine.com and www.necksurgery.com.
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 27, 2007. Actual results may differ materially from anticipated results.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsMedtronic Expands ENT Portfolio with FDA Clearance of NIM Vital(TM) Next Generation Intraoperative Nerve Monitoring System and Acquisiton of Ai Biomed Corp.
Medtronic Launches Head-to-Head TAVR Study Comparing the Evolut(TM) TAVR Platform Against the Edwards SAPIEN Valve in Small Annulus Patients
Medtronic Announces First Patient Implanted in ELITE Study of InterStim(TM) Micro